These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2. Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934 [TBL] [Abstract][Full Text] [Related]
5. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics. Nagler A; Kalaora S; Barbolin C; Gangaev A; Ketelaars SLC; Alon M; Pai J; Benedek G; Yahalom-Ronen Y; Erez N; Greenberg P; Yagel G; Peri A; Levin Y; Satpathy AT; Bar-Haim E; Paran N; Kvistborg P; Samuels Y Cell Rep; 2021 Jun; 35(13):109305. PubMed ID: 34166618 [TBL] [Abstract][Full Text] [Related]
6. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4 Chen Y; Mason GH; Scourfield DO; Greenshields-Watson A; Haigh TA; Sewell AK; Long HM; Gallimore AM; Rizkallah P; MacLachlan BJ; Godkin A Cell Rep; 2023 Aug; 42(8):112827. PubMed ID: 37471227 [TBL] [Abstract][Full Text] [Related]
7. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity. Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. Kiyotani K; Toyoshima Y; Nemoto K; Nakamura Y J Hum Genet; 2020 Jul; 65(7):569-575. PubMed ID: 32372051 [TBL] [Abstract][Full Text] [Related]
9. Immunoinformatics prediction of overlapping CD8 Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794 [TBL] [Abstract][Full Text] [Related]
10. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Parker R; Partridge T; Wormald C; Kawahara R; Stalls V; Aggelakopoulou M; Parker J; Powell Doherty R; Ariosa Morejon Y; Lee E; Saunders K; Haynes BF; Acharya P; Thaysen-Andersen M; Borrow P; Ternette N Cell Rep; 2021 May; 35(8):109179. PubMed ID: 34004174 [TBL] [Abstract][Full Text] [Related]
11. A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2. Jin X; Liu X; Shen C Virus Res; 2023 Jan; 324():199024. PubMed ID: 36526016 [TBL] [Abstract][Full Text] [Related]
12. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles. Becerra-Artiles A; Calvo-Calle JM; Co MD; Nanaware PP; Cruz J; Weaver GC; Lu L; Forconi C; Finberg RW; Moormann AM; Stern LJ Cell Rep; 2022 Jun; 39(11):110952. PubMed ID: 35675811 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8 Lopes-Ribeiro Á; Oliveira PM; Retes HM; Barbosa-Stancioli EF; da Fonseca FG; Tsuji M; Coelho-Dos-Reis JGA Front Immunol; 2023; 14():1229712. PubMed ID: 38022506 [TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592 [TBL] [Abstract][Full Text] [Related]
16. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance. Marchan J Hum Immunol; 2020; 81(10-11):588-595. PubMed ID: 32888767 [TBL] [Abstract][Full Text] [Related]
17. HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection. Augusto DG; Hollenbach JA Curr Opin Immunol; 2022 Jun; 76():102178. PubMed ID: 35462277 [TBL] [Abstract][Full Text] [Related]
18. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope. Dolton G; Rius C; Hasan MS; Wall A; Szomolay B; Behiry E; Whalley T; Southgate J; Fuller A; ; Morin T; Topley K; Tan LR; Goulder PJR; Spiller OB; Rizkallah PJ; Jones LC; Connor TR; Sewell AK Cell; 2022 Aug; 185(16):2936-2951.e19. PubMed ID: 35931021 [TBL] [Abstract][Full Text] [Related]
19. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2. Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ bioRxiv; 2022 Dec; ():. PubMed ID: 36482973 [TBL] [Abstract][Full Text] [Related]
20. Landscape and selection of vaccine epitopes in SARS-CoV-2. Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]